Research of chemokines and platelet-derived microparticles in progression of thrombotic vascuritis

趋化因子和血小板衍生微粒在血栓性血管炎进展中的研究

基本信息

  • 批准号:
    11670718
  • 负责人:
  • 金额:
    $ 2.18万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

We we used flow cytometry and confocal laser scanning microscopy to investigate the effects of high-shear-induced platelet and microparticle activation in adhesion molecules of THP-1 and endothelial cells (ECs). We also measured the production of some cytokines and studied cytokine mRNA from THP-1 and ECs after PMP stimulation. PMP stimulation of THP-1 cells increased CD11b, CD32, and CD33 but not CD29, CD31, and CD36. PMP stimulation of ECs increased CD54 and CD63 but not CD9, CD29, and CD31. PMPs induced IL-8, IL-1β, and TNFα production by THP-1. PMPs also induced IL-8, IL-1β, and IL-6 production by ECs. Production was time-dependent. With RT-PCR, some cytokine mRNAs were detected in THP-1 and ECs after PMP stimulation. In relation to adhesiveness after PMP stimulation, we could clearly observe a shift in distribution not only of CD11b in THP-1 cells but also of CD54 in ECs.Levels of PMPs and platelet activation markers(Annexin V and CD62P on activated platelets), chemokines(IL-8, monocyte chemotactic peptide 1[MCP-1], and regulated on activation normally T-cell expressed and secreted [RANTES]), and selectins(P-selectin and E-electin)in diabetic patients and healthy control subjects in order to develop a better understanding of their potential contribution to diabetic vascular complications. Significant increases were found for PMPs, P-selectin, MCP-1, RANTES and soluble P- and E-selectins in diabetic individuals, whereas IL-8 levels were similar. These results suggest that high-shear-induced microparticles may contribute to the development of atherosclerosis and participate in vascular damage in inflammatory disorders.
我们利用流式细胞仪和激光共聚焦扫描显微镜研究了高切诱导的血小板和微粒子激活对THP-1和内皮细胞(ECs)黏附分子的影响。我们还检测了PMP刺激后THP-1和ECs产生的一些细胞因子,并研究了细胞因子mRNA的表达。PMP刺激THP-1细胞增加CD11b、CD32和CD33,但不增加CD29、CD31和CD36。PMP刺激内皮细胞可增加CD54和CD63,但不增加CD9、CD29和CD31。PMPs通过THP-1诱导IL-8、IL-1β和肿瘤坏死因子α的产生。PMPs还可诱导内皮细胞产生IL-8、IL-1β和IL-6。生产是依赖时间的。逆转录-聚合酶链式反应检测到PMP刺激后THP-1和ECs中一些细胞因子的mRNAs。在PMP刺激后的黏附方面,我们不仅可以清楚地观察到CD11b在THP-1细胞中的分布,也可以清楚地观察到CD54在ECs中的分布变化。为了更好地了解它们在糖尿病血管并发症中的潜在作用,糖尿病患者和健康对照组中PMPs和血小板激活标志物(活化的血小板上的Annexin V和CD62p)、趋化因子(IL-8、单核细胞趋化肽1[MCP-1]和活化调节T细胞正常表达和分泌[RANTES])以及选择素(P-选择素和E-选择素)的水平发生了变化。糖尿病患者血浆PMPs、P-选择素、MCP-1、RANTES、可溶性P-选择素和E-选择素水平显著升高,而IL-8水平无明显变化。这些结果表明,高切变诱导的微粒可能参与了动脉粥样硬化的发展,并参与了炎性疾病中的血管损伤。

项目成果

期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Omoto S, Nomura S, Shouzu A, et al.: "Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy"Nephrone. 81. 271-277 (1999)
Omoto S、Nomura S、Shouzu A 等人:“血小板衍生微粒和活化血小板在糖尿病肾病中的意义”Nephrone。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shosaku Nomura: "Platelet-derived microparticles in patients with arteriosclerosis obliterans : enhancement of high shear-induced microparticle generation by cytokines"Thrombosis Research. 98. 257-268 (2000)
Shosaku Nomura:“动脉硬化闭塞症患者的血小板衍生微粒:细胞因子增强高剪切诱导的微粒生成”血栓形成研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kagawa H, Nomura S, Ozaki Y, et al.: "Effects of nilvadipine-levels and soluble factors in collagen disease complicated with essential hypertension"clinical and Experimental Hypertension. 21. 1177-1188 (1999)
Kakawa H、Nomura S、Ozaki Y 等人:“尼伐地平水平和可溶性因子对胶原病并发原发性高血压的影响”临床和实验性高血压。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shosaku Nomura: "Platelet-derived microparticles in patients with arteriosclerosis obliterans : enhancement of high shear-induced microparticle generation by cytokines"Throm Res. 98. 257-268 (2000)
Shosaku Nomura:“动脉硬化闭塞症患者中的血小板衍生微粒:细胞因子增强高剪切诱导的微粒生成”Throm Res。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nomura S, Imamura A, Okuno M, et al.: "Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticles generation by cytokines"Thrombosis Research. (in press).
Nomura S、Imamura A、Okuno M 等人:“动脉硬化闭塞症患者中的血小板衍生微粒:细胞因子增强高剪切诱导的微粒生成”血栓形成研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NOMURA Shosaku其他文献

NOMURA Shosaku的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NOMURA Shosaku', 18)}}的其他基金

Development of the early diagnostic method of intractable ITP using single nucleotide polymorphism analysis of the cytokine gene and EV
利用细胞因子基因和EV的单核苷酸多态性分析开发难治性ITP早期诊断方法
  • 批准号:
    19K07948
  • 财政年份:
    2019
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Induction and maintenance of Th2 immune responses by T-lymphocyte-derived microparticle
T 淋巴细胞衍生微粒诱导和维持 Th2 免疫反应
  • 批准号:
    15K08657
  • 财政年份:
    2015
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New method of evaluation and diagnosis for DIC using endothelial cell-derived microparticles
使用内皮细胞微粒评估和诊断 DIC 的新方法
  • 批准号:
    23590694
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effect of high shear stress-dependent platelet-derived microparticle for the interaction of monocyte and endothelial cell
高剪切应力依赖性血小板衍生微粒对单核细胞与内皮细胞相互作用的影响
  • 批准号:
    13670760
  • 财政年份:
    2001
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus.
开发用于局部治疗红斑狼疮皮肤表现的内源性大麻素微粒制剂。
  • 批准号:
    10699531
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
Hydrogel microparticle technology for high-throughout screening of chimeric antigen receptor-T cells based on single cell effector function
基于单细胞效应功能的嵌合抗原受体T细胞高通量筛选水凝胶微粒技术
  • 批准号:
    10604170
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
Bioerodible corticosteroid microparticle-drug as an intra-articular drug delivery system for osteoarthritis therapy
可生物侵蚀的皮质类固醇微粒药物作为骨关节炎治疗的关节内药物递送系统
  • 批准号:
    10709663
  • 财政年份:
    2022
  • 资助金额:
    $ 2.18万
  • 项目类别:
Immunoregulatory effect of microparticle delivered STING agonist in the control of experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS)
微粒递送的 STING 激动剂在控制实验性自身免疫性脑脊髓炎 (EAE) 和多发性硬化症 (MS) 中的免疫调节作用
  • 批准号:
    10392967
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
Tolerogenic dual microparticle system for treatment of multiple sclerosis
用于治疗多发性硬化症的致耐受性双微粒系统
  • 批准号:
    9918870
  • 财政年份:
    2017
  • 资助金额:
    $ 2.18万
  • 项目类别:
Circulating microparticle effects on phenotypically distinct pulmonary endothelium
循环微粒对表型不同的肺内皮的影响
  • 批准号:
    9256870
  • 财政年份:
    2017
  • 资助金额:
    $ 2.18万
  • 项目类别:
Microparticle resiquimod for the treatment of visceral leishmaniasis
瑞西莫德微粒治疗内脏利什曼病
  • 批准号:
    9259909
  • 财政年份:
    2016
  • 资助金额:
    $ 2.18万
  • 项目类别:
Microparticle resiquimod for the treatment of visceral leishmaniasis
瑞西莫德微粒治疗内脏利什曼病
  • 批准号:
    9091911
  • 财政年份:
    2016
  • 资助金额:
    $ 2.18万
  • 项目类别:
The Role of Pyroptosis Induced Intestinal Epithelial Cell Extrusion in the Pathogenesis of Inflammatory Bowel Disease
焦亡诱导的肠上皮细胞挤出在炎症性肠病发病机制中的作用
  • 批准号:
    241787
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Salary Programs
Synthetic microparticle malaria vaccine
合成微粒疟疾疫苗
  • 批准号:
    8870276
  • 财政年份:
    2010
  • 资助金额:
    $ 2.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了